Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 1,795

Document Document Title
WO/1989/012640A1
A ligated technetium (III/II) complex is useful as a brain perfusion imaging agent. The complex has a technetium (III/II) center surrounded by six ligating moieties. The complex preferably has a reduction potential Tc(III) to Tc(II) whic...  
WO/1989/011875A1
A method is provided utilizing contrast agents which provide increased diagnostic information in the magnetic resonance image of the hepatobiliary system and alimentary tract, especially the small intestine. Novel contrast agents which a...  
WO/1989/011877A2
The present invention provides conjugates formed from calcified tissues targeting agents and radiolabeled compounds. One such conjugate comprises a chelate and a targeting agent that is capable of associating with calcified tissue, where...  
WO/1989/012058A2
The present invention constitutes a class of organometallic complexes which reversibly react with hydrogen to form dihydrides and processes by which these compounds can be utilized. The class includes bimetallic complexes in which two cy...  
WO/1989/012049A1
The new derivatives of metalloporphyrines in accordance with the invention are described in formula (I), in which A and B each represent (alpha) or (beta) and Z+ represents N+-R1 or C-N+R1R2R3, R1 being a straight aliphatic group of bran...  
WO/1989/011475A1
The invention is a chelate having general formula (I), wherein R1-4 is -CH2COOH; n is 1 to 5; X is a member selected from the group consisting of -NO2, -NH2, -NCS, -NHCOCH2-Z with Z being a member selected from the group consisting of Br...  
WO/1989/010759A1
The invention relates to a method of preparing a diaminedithiol chelating agent by reacting a cyclic diamine disulfide with a thiol compound as a reducing agent, said thiol compound being selected from the group consisting of dithiothrei...  
WO1989008657A3  
WO/1989/008657A2
Preparation of 99m technetium or 186 rhenium or 188 rhenium compounds usable as radiopharmaceutical products. To obtain said preparation an oxygenated compound of 99mTc, 186Re or 188Re, for example an ammonium or alcaline metal pertechne...  
WO/1989/004302A1
Electrochemiluminescent moieties having the formula [Re(P)m(L1)n(L2)o(L3)p(L4)q(L5)r(L6)s]t(B)u, wherein P is a polydentate ligand of Re; L1, L2, L3, L4, L5 and L6 are ligands of Re, each of which may be the same as or different from eac...  
WO/1989/003388A1
The invention concerns cationic complexes of Technetium-99m with bidentate ligands (L), including complexes having the formulae [Tc(NO) X L2]+ and [Tc L3]+, which are of interest as heart imaging agents. The ligands are characterized by ...  
WO/1989/002433A1
Tris(isonitrile)copper(I) complex salts with anions selected from BF4, PF6, Cl04, I, Br, Cl and CF3COO are useful in preparing radionuclide complexes rapidly at room temperature. Preferred isonitrile ligands are ether isonitriles. The tr...  
WO/1989/001331A1
Tertiary butyl esters of anticancer drugs are provided which have formula (I), wherein R1 and R2 are the same or different and are selected from the group consisting of H, F, Cl, Br, and I and R2 can also be NH2; R3, R4, and R5 are the s...  
WO/1988/008720A1
Complexes useful as radiopharmaceuticals contain the 99mTc-NO moiety and a ligand which confers biological target-seeking properties on the complex. Preferred are mono-cationic complexes, particularly having the formula: [99mTc(NO)L2X]+,...  
WO/1988/006154A1
Molecular systems formed from ordered heterometallic chains containing A and B ions with different spins, connected by bis-bidentate ligands which, due to their substituent (s), are capable of creating a strong steric hindrance around th...  
WO/1988/005439A1
Complex comprised of a bioreagent alkilated-complexed by an organo-metallic compound. Said organo-metallic compound comprises a cluster of alcyne-carbonyle metal. Application of complexes of bioreagents as tracers for dosings of biologic...  
WO/1987/007608A1
Perfluoroalkylcyclopentadienylthallium compounds of general formula (I), wherein n = 1-5 which are useful to modify the properties of transition metal complexes by the introduction of an electron-withdrawing perfluoroalkylcyclopentadieny...  
WO/1987/007608A2
Perfluoroalkylcyclopentadienylthallium compounds of general formula (I), wherein n = 1-5 which are useful to modify the properties of transition metal complexes by the introduction of an electron-withdrawing perfluoroalkylcyclopentadieny...  
WO/1987/003605A1
Oligomers are produced from unsaturated monomers. They contain terminal unsaturation and have a degree of polymerization of from 2 to 200. These oligomers are produced by the free radical polymerization of unsaturated monomers using as a...  
WO/1987/001721A1
Metal complexes of hydroxyl and/or thiol containing Mannichs are prepared by reacting a transition metal containing agent with an aromatic Mannich. The Mannich is prepared from a substituted hydroxyl and/or thiol containing aromatic, an ...  
WO/1987/001290A1
A coordination complex comprising a radionuclide selected from the class consisting of radioactive isotopes of Tc, Ru, Co, Pt and Re and an isonitrile ligand of the formula: (CNX)R, where X is a lower alkyl group having 1 to 4 carbon ato...  
WO/1986/002841A1
Homologs of Diamide-DTPA-Paramagnetic compounds (such as diamido acetyl diethylene triamine triacetic acid) provide excellent contrast agents for magnetic resonance (MR) imaging. The magnetic dipole generated by the unpaired electron wit...  
WO/1986/003010A1
Method for labelling amine-containing compounds like proteins with a metal, particularly technetium-99m comprising reacting metal ions in an acidic medium with a compound represented by formulae (I) or (II), wherein R1, R2 and R3 are ind...  
WO/1986/002005A1
Homologs of Diester-DTPA-Paramagnetic compounds (such as dimethyl acetyl diethylene triamine triacetic acid) provide excellent contrast agents for magnetic resonance imaging (MRI). The magnetic dipole generated by the unpaired electron w...  
WO/1986/000897A1
A dihydropyridine$(1,7)$pyridinium salt type of redox, or chemical, delivery system for the site-specific and/or site-enhanced delivery of a radio-nuclide to the brain. A chelating agent capable of chelating with a radionuclide and havin...  
WO/1985/005617A1
New N- AD2-(4-fluoro-phenyl)-1-methyl BD-ethyl-N-methyl-N-propynyl amine of the general formula (I), and isomers and salts thereof. The compound of the formula (I) is useful as medicine. The compound of the formula (I), may be prepared b...  
WO/1985/004406A1
Novel vicinal dioxyalkylene organometalates comprising a cation having hydrocarbyl-containing substituent. The vicinal dioxyalkylene organometalates can be reacted with water to yield alkylene glycols.  
WO/1985/003871A1
A method of prophylaxis or treatment of atheromatosis in susceptible vertebrates comprising administration of manganese-containing pharmaceutical preparations in appropriate ratios of tryptophan to manganese to prevent development and pr...  
WO/1985/003873A1
Method of treatment of hypertension and toxemia of pregnancy in vertebrates. It comprises the administration of manganese-containing pharmaceutical preparations in appropriate ratios with tryptophan to lower the blood pressure. These are...  
WO/1985/003872A1
Method of lowering blood glucose in vertebrates comprising administration of manganese-containing pharmaceutical preparations in appropriate ratios with arginine, leucine, ornithine, tryptophan and valine and in appropriate ratios as bet...  
WO/1985/003869A1
Method of treatment for memory disorders of the elderly comprising administering manganese-containing pharmaceutical preparations in appropriate ratios with isoleucine, methionine, phenylalanine, tyrosine and valine and in appropriate ra...  
WO/1985/003870A1
Method of raising blood glucose in vertebrates comprising administration of manganese-containing pharmaceutical preparations in appropriate ratios with isoleucine, methionine, phenylalanine, tyrosine and valine and in appropriate ratios ...  
WO/1985/003874A1
Method of treatment for depression in vertebrates and other organisms comprising administration of manganese-containing pharmaceutical preparations in appropriate ratios with phenylalanine and tyrosine to return the emotional state of th...  
WO/1985/000955A1
A biocidal composition, particularly a fungicidal and/or bactericidal composition, comprising a thiosemicarbazone having the general formula (I), and their complexes formed by reaction with compounds of the metals Cu, Zn, Mn, Fe, Ca, Mg,...  
WO/1983/003761A1
A coordination complex of an isonitrile ligand and radionuclide such as Tc, Ru, Co, Pt, Fe, Os, Ir, W, Re, Cr, Mo, Mn, Ni, Rh, Pd, Nb and Ta, is useful as a diagnostic agent for labelling liposomes or vesicles, and selected living cells ...  
WO/1983/002615A1
A composition useful for preparing cationic lipophilic technetium complexes for radiodiagnostic imaging. The composition comprising an admixture of (a) an accelerator compound selected from the group of water-soluble organic bidentate li...  
WO/1983/001450A1
A normally solid, hydrophilic compound capable of binding with Tc-99m to form a cationic complex. The compound has a formula selected from:$(30,)$wherein: R, R', R'', R''', R1, R2, R3, R4, R5. R6. R21, R22 and R23 are each independently ...  
WO/1981/003494A1
Manganese compounds of the formula MnIILX2(Q)n (I) wherein L is a monodentate ligand of the formula PR1R2R3 (II) wherein R1, R2, and R3 are identical or different and are substituted or unsubstituted alkyl, cycloalkyl, alkenyl, alkynyl, ...  
WO/1980/001690A1
Compositions of matter which are highly useful in hydroformylation processes. The compositions are non-charged, non-chelated bis- and tris-(alkyl diaryl phosphine) rhodium carbonyl hydrides. The substituents of the alkyl group include he...  
WO/1980/001692A1
Complexes of the formula (FORMULA) in which R is selected from an alkyl group containing 1 to 30 carbon atoms and an aryl group containing from 6 to 10 carbon atoms; Q is a divalent organic radical selected from an alkylene group and an ...  
WO/1980/001689A1
Novel ligand materials and transition metal complexes thereof which are useful as solvents and/or catalysts for various processes, including catalytic conversion processes for the conversion of hydrocarbons or carbon monoxide, such as th...  
WO/1980/001691A1
A process in which an alpha-olefin containing n carbon atoms is reacted with hydrogen and carbon monoxide in the presence of a complex rhodium-containing catalyst and a base to form aldehydes containing 2n+2 carbon atoms, wherein the rea...  
WO/1979/000696A1
Compounds of formula 1 are useful in the separation of a gas such as oxygen, hydrogen, sulphur dioxide, alkenes and carbon monoxide from a fluid comprising the gas. I MnIILX2 In formula I: L represents a monodentate ligand of formula IA ...  
JP2019167365A
[Subject] Offer of a probe for use in detection of cancer which reveals a gastrin-releasing-peptide receptor (GRPR), imaging, diagnosis, targeting, medical treatment, etc. [Means for Solution] A GRPR antagonist shown by the following gen...  
JP6564785B2  
JP2019521127A
The present invention relates to a manganese (II) complex, and its manufacturing method and use, and is the structure (R) of the above-mentioned complex.1R2R3R4A)2[MnX4It is]. Inside of it, R1R2R3 Is , R4Although it is the same, or it ma...  
JP6529173B2  
JP6497680B2  
JP6440695B2  
JP2018522959A
The present invention provides a compound luminescent material. The compound luminescent material distributes the above-mentioned perovskite-type nanoparticle to the above-mentioned matrix including a matrix and a perovskite-type nanopar...  

Matches 601 - 650 out of 1,795